1型糖尿病神经发育障碍与血糖控制及并发症全国队列研究
研究发现共病神经发育障碍尤其ADHD与血糖控制不佳及糖尿病肾病、视网膜病变风险升高相关,智力障碍者肾病风险尤高。
要点
- 共病神经发育障碍与1型糖尿病血糖控制不佳相关,ADHD关联最强(OR 2.31)。
- 共病神经发育障碍增加糖尿病肾病(HR 1.72)和视网膜病变(HR 1.18)风险。
- 智力障碍患者肾病风险显著升高(HR 2.64),需加强监测。
核心结论
- 儿童期起病1型糖尿病共病神经发育障碍(主要为ADHD和智力障碍)与血糖控制不佳及糖尿病并发症风险升高相关。
主要发现
- 中位随访7.5年(IQR 3.9-11.2),任何神经发育障碍与血糖控制不佳(平均HbA1c>8.5%)相关(ORadj 1.51,95%CI 1.13-2.03),ADHD关联更强(ORadj 2.31,95%CI 1.54-3.45)。
- 共病神经发育障碍者肾病风险升高(HRadj 1.72,95%CI 1.21-2.44),视网膜病变风险升高(HRadj 1.18,95%CI 1.00-1.40)。
- ADHD患者肾病风险升高(HRadj 1.90,95%CI 1.20-3.00),视网膜病变风险升高(HRadj 1.33,95%CI 1.07-1.66)。
- 智力障碍患者肾病风险尤其升高(HRadj 2.64,95%CI 1.30-5.37)。
临床怎么用
- 对儿童期起病1型糖尿病共病神经发育障碍(尤其ADHD和智力障碍)者,应关注血糖控制并加强糖尿病并发症筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Neurodevelopmental disorders are more prevalent in childhood-onset type 1 diabetes than in the general population, and the symptoms may limit the individual's ability for diabetes management. OBJECTIVE: This study investigated whether comorbid neurodevelopmental disorders are associated with long-term glycemic control and risk of diabetic complications. METHODS: This population-based cohort study used longitudinally collected data from Swedish registers. We identified 11 326 individuals born during 1973-2013, diagnosed with type 1 diabetes during 1990-2013 (median onset age: 9.6 years). Among them, 764 had a comorbid neurodevelopmental disorder, including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, and intellectual disability. We used multinomial logistic regression to calculate odds ratios (ORs) of having poor glycemic control (assessed by glycated hemoglobin [HbA1c]) and Cox regression to estimate hazard ratios (HRs) of nephropathy and retinopathy. RESULTS: The median follow-up was 7.5 years (interquartile range [IQR] 3.9, 11.2). Having any neurodevelopmental disorder (ORadjusted 1.51 [95% CI 1.13, 2.03]), or ADHD (ORadjusted 2.31 [95% CI 1.54, 3.45]) was associated with poor glycemic control (mean HbA1c > 8.5%). Increased risk of diabetic complications was observed in patients with comorbid neurodevelopmental disorders (HRadjusted 1.72 [95% CI 1.21, 2.44] for nephropathy, HRadjusted 1.18 [95% CI 1.00, 1.40] for retinopathy) and patients with ADHD (HRadjusted 1.90 [95% CI 1.20, 3.00] for nephropathy, HRadjusted 1.33 [95% CI 1.07, 1.66] for retinopathy). Patients with intellectual disability have a particularly higher risk of nephropathy (HRadjusted 2.64 [95% CI 1.30, 5.37]). CONCLUSION: Comorbid neurodevelopmental disorders, primarily ADHD and intellectual disability, were associated with poor glycemic control and a higher risk of diabetic complications in childhood-onset type 1 diabetes.
引用
- Liu S, Kuja-Halkola R, Larsson H, et al. Neurodevelopmental Disorders, Glycemic Control, and Diabetic Complications in Type 1 Diabetes: a Nationwide Cohort Study. J Clin Endocrinol Metab. 2021. PMID: 34171098. doi:10.1210/clinem/dgab467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。